Safety of meningococcal polysaccharide vaccine serogroup "A" (Pilot Study).
2000 subjects were vaccinated with sero-group "A" meningococcal polysaccharide vaccine during a meningitis outbreak and the opportunity was taken to study the side effects of the procedure. There were no major side effects and the vaccine was found to be quite safe.
D000293:Adolescent; D000328:Adult; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008585:Meningitis, Meningococcal / Q000517:prevention & control*; D009345:Neisseria meningitidis / Q000276:immunology*; D010865:Pilot Projects; D015024:Zambia
D001428:Bacterial Vaccines